Net income was $239.6 million or $1.14 a share, compared to $213.1 million, or 98 cents a share for the year-ago quarter. That was ahead of analysts’ consensus for $1.08 a share.
Sales increased 7% to $2.73 billion from $2.55 billion a year ago, ahead of the $1.71 billion analysts expected. Comparable store sales grew 2%.
The results were 6 cents above Stifel analysts’ estimate and at the high end of management’s guidance. Results benefited by 2 cents a share due to a favorable resolution of a legal matter. Excluding this benefit, EPS increased 14%.
CEO Barbara Rentler, said: “Our second quarter sales performed at the high-end of our expectations as today’s value-focused consumers continued to respond to our wide assortment of competitive name brand bargains.”
Stifel analyst Richard Jaffe, noted: “Solid results on top of strong year-on-year comparisons as the off-price sector remains favored with customers who are responding positively to the company’s competitively priced, appealing, nationally recognized, branded merchandise.”
Looking ahead, for the third quarter, earnings per share are projected to be 83 to 87 cents, up from 80 cents a year ago. Fourth quarter projections are for $1.05 to $1.09 a share.
Ross raised its fiscal 2014 earnings guidance to a range of $4.18 to $4.2
For commercial purposes, extract supplements can be obtained from the fruit of the pericarp. Garcinia cambogia reviews is performed by a physician Chen and Oz to prove that it is an herb for weight loss, a lot of research has been done. Studies, Garcinia cambogia extract supplementation decreases the weight of the body fat accumulation, was shown to have a positive effect on prevention. We are important substances such as cholesterol (LDL), reduces the serum leptin and triglycerides. In addition, it will increase the level of serotonin and cholesterol (HDL). The study also, Garcinia cambogia extract supplements, has proven that there are no significant adverse effects on many of the eight weeks, such as its use.